Document is current
Any future updates will be listed below
-
Authors
Marzano, Angelo Valerio
Magnoni, Cristina
Micali, Giuseppe
De Magnis, Angelina
Pintori, Giuseppina
Fiorini, Simone
Simonella, Valentina
Bastioli, Linda
Nappi, Francesca
Pappagallo, Giovanni
Prignano, Francesca
-
Funding
Funding for this research was provided by:
Novartis Farma SpA
Università degli Studi di Milano
- License Information
-
More Information
Article History
Received: 5 June 2024
Revised: 5 June 2024
Accepted: 5 August 2024
First Online: 24 August 2024
Declarations
:
: A.V. Marzano reports consultancy/advisory board disease-relevant honoraria from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, Leopharma, Novartis, Pfizer, Sanofi, and UCB. F. Prignano has received consulting fees from AbbVie, Amgen, Biogen, Eli-Lilly, Janssen-Cilag, Leo-Pharma, Sanofi, Boehringer-Ingelheim and Novartis and has received research grants from Janssen-Cilag, Novartis, and SIDeMAST.
